News | Radiation Therapy | June 29, 2017

IBA Announces ICC Radiotherapy Training Course Accreditation by EBAMP

Course provides radiation therapy and medical imaging dosimetry professionals with hands-on training

June 29, 2017 — IBA announced the accreditation of an International Competence Center (ICC) training course by the European Board for Accreditation in Medical Physics (EBAMP).

IBA Dosimetry successfully passed the evaluation for its ICC training course “Small Fields and FFF: The New Regulation DIN 6809-8 in Theory and Hands-on Practice.” This is the first training for which IBA applied for accreditation under the new procedure set by the European Federation of Medical Physics Associations (EFOMP). The training was judged according to the EBAMP protocol and has been assigned with 23 credit points at EQF Level 7.

Following a new European Accreditation procedure for trainings in Medical Physics, EFOMP has installed the committee EBAMP. The committee strictly evaluates training courses regarding their content, course material and qualification of the lecturers.

Dr. Lutz Müller, director of the ICC, said, “We are proud of having the first ICC course accredited under the new procedure which confirms the professional standard of our course offerings in terms of program, lecturers and state-of-the-art infrastructure including a clinical linac [linear accelerator]. I have always seen the ICC as an international platform for exchange between physicists. Since its very beginning, we have had students in all our classes from various European countries. The new accreditation system strengthens the ‘European Spirit’ and adds a great value to our course participants.”

IBA Dosimetry believes ongoing education and training are among the most important functions for medical physicists to achieve the highest level of clinical safety and efficiency. The company developed the CAREprogram, which supports customers with enhanced trainings, expert services and engaging events. As an Enhanced Trainings initiative, IBA Dosimetry built the ICC, where radiation therapy and medical imaging dosimetry healthcare professionals have the opportunity to experience hands-on enhanced training courses, which help them optimize their clinical applications using IBA Dosimetry’s integrated quality assurance technology, as well as other modalities.

For more information:

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more